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Are intrasac pressure measurements useful after
endovascular repair of abdominal aortic
aneurysms?
Ross Milner, MD,a Paola De Rango, MD,b Fabio Verzini, MD,b and Piergiorgio Cao, MD,c Maywood, Ill;
and Perugia and Rome, Italy
Fewwould argue with the need for long-term follow-up after endovascular repair of abdominal aortic aneurysms. A small
risk of reintervention persists and the challenge remains to identify those patients that will require additional procedures
to prevent subsequent complications. The ideal follow-up regimen remains elusive. Up until this point, most regimens
have consisted of radiologic imaging, with either computed tomography (CT) scans or ultrasonography to identify
continued aneurysm perfusion (endoleaks) and document sac dynamics, either shrinkage, growth, or stability. However,
aneurysm sac growth or shrinkage serves only as a surrogate measurement for pressurization, and although it is uniformly
believed that attachment site endoleaks require treatment, it remains controversial as to how to determine which type II
endoleaks pressurize an aneurysm sufficiently to require therapy.
In response to these difficulties, several manufacturers have developed pressure sensors that can be implanted at the
time of the initial repair. They have been shown capable of measuring intrasac pressures that have appropriately
responded to reinterventions for endoleaks. However, are they the answer we are looking for? Are they ready for
widespread use? Do they offer a reliable and consistent measure of intrasac pressure that can be trusted to determine the
need, or lack of need, for further therapy? Our debaters will try to convince us one way or another. ( J Vasc Surg 2011;
53:534-9.)
n
i
c
p
i
r
(
v
G
a
p
s
s
p
p
a
d
w
t
w
s
rPART I. SERIAL SAC PRESSURE
MEASUREMENTS CAN DETERMINE WHICH
TYPE II ENDOLEAKS CAN BE TREATED
Ross Milner, MD, Maywood, Ill
Introduction: Repair of abdominal aortic aneurysms
(AAAs) was revolutionized by the introduction of endovas-
cular aneurysm repair (EVAR) by Dr Juan Parodi.1 The
devices used to treat aortic aneurysms have improved sig-
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534ificantly since his initial report in 1991. Therefore, the
ncidence of device-related endoleaks (type I and III) oc-
urs less frequently in this third decade of EVAR as com-
ared to when devices first received Food & Drug Admin-
stration approval. On the other hand, type II endoleaks
emain controversial. The branch vessel filling of the sac
eg, inferior mesenteric artery and lumbar arteries) leads to
ariability in the behavior of the residual aneurysm sac.
Pressure sensing technology (CardioMEMS, Atlanta,
a) has been proven efficacious in the acute exclusion of
neurysms with an endograft.2 Long-term surveillance with
ressure sensors is still being evaluated. I hope to demon-
trate to you that I am correct about the utility of pressure
ensors to determine therapy for type II endoleaks as op-
osed to Professor Cao’s opinion that there is no benefit for
ressure sensing in relationship to type II endoleaks.
Endoleaks and pressure sensors. As mentioned
bove, pressure sensors have been shown to be effective in
etermining the acute exclusion of an aneurysm treated
ith an endograft. There is more evidence in the literature
hat sensors are effective for longer-term surveillance as
ell.3,4 These two studies show the efficacy of sensors in
urveillance after EVAR and thoracic endovascular aneu-
ysm repair (TEVAR) in relation to both type I and type III
ndoleaks. Both studies show that, in general, the mea-
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Volume 53, Number 2 Milner et al 535sured pressure is reduced as the residual aneurysm sac
shrinks except when a type I or III endoleak is present.
Hoppe et al3 reported only two type II endoleaks in their
series of patients treated for abdominal aortic aneurysms.
Both of these leaks were associated with a low residual sac
pulse pressure. Parsa et al4 followed 7 patients with type II
endoleaks after TEVAR. Once again, the residual sac pulse
pressure was low and the aneurysm sacs were not enlarging.
Ellozy et al5 presented their experience at Mount Sinai
in New York with a pressure-sensing technology that is not
being utilized currently (Remon Medical Technologies,
Caesarea, Israel). This technology is based on ultrasound
scans rather than radiofrequency (CardioMEMS), but
serves an identical purpose of sac pressure monitoring.
Their experience was small, overall, but a few patients had
type II endoleaks. The pressure was elevated in 2 patients
with type II endoleaks. These 2 patients did not have sac
expansion. Several others had type II endoleaks with either
low residual sac pressure or a resolved endoleak on
follow-up imaging.
Personal experience. We placed almost 70 remote
pressure sensors (CardioMEMS) in patients at Emory Uni-
versity Hospital undergoing endovascular abdominal aortic
aneurysm repair over a 2-year period of time. In addition,
we were one of the 11 sites in the APEX trial. Most patients
had low residual pulse pressure in the sac that correlated
well with exclusion, both in the short term and on
follow-up surveillance. Several type I endoleaks were
treated intraoperatively, and two type III endoleaks were
detected on follow-up surveillance and treated with cuff
placement for iliac limb modular disconnections. Both
patients had expanding aneurysm sacs and elevated pulse
pressures. One type III endoleak was seen at 6-month
follow-up. The second was noted on 2-year evaluation.
Both patients have been problem-free since their secondary
intervention with cuff placement. The residual pulse pres-
sure was very low in both with shrinking aneurysm sacs.
Consistent with the published literature, our experi-
ence with type II endoleaks has been limited. I have two
examples that will help explain the potential of pressure
sensing for the detection of type II endoleaks. The first
patient had a low residual pulse pressure and a shrinking
aneurysm sac (Fig 1). The second patient had an elevated
pulse pressure and an expanding aneurysm sac (Fig 2). This
patient was diagnosed with an intracranial malignancy just
before his planned secondary intervention. Therefore, his
procedure was canceled. He has not had a follow-up visit
since that time.
Treatment of type II endoleaks. So, does pressure
sensing determine which type II endoleaks need to be
treated? I think the answer is “yes” and “no” with the
current literature support. An elevated pressure in associa-
tion with an expanding aneurysm sac needs to be treated. A
low residual pulse pressure with a stable or shrinking sac
does not need treatment. The gray zone is more difficult to
determine.
There is not an absolute number or residual pulse
pressure that can be used to make a decision to treat a type
4I endoleak. I hope that as experience grows with pressure
ensors in the literature, that type II treatment will be better
escribed. It would be ideal to treat an aneurysm based on
esidual pulse pressure prior to aneurysm sac expansion and
he risk of rupture.
EFERENCES
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491-9.
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results of wireless pressure sensing for endovascular aneurysm repair: the
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sion. J Vasc Surg 2007;45:236-42.
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ig 1. Sac pressure tracing from a patient with a type II endoleak
nd a shrinking aneurysm sac. The residual pulse pressure is 6 mm
g with a ratio of 0.06 (sac pulse pressure/systemic pulse
ressure).
ig 2. Sac pressure tracing from a patient with an elevated pres-
ure and expanding aneurysm sac. The sac has grown from 5.2 to
.7 cm with a ratio of 0.4.. Parsa CJ, Daneshamand MA, Lima B, Belsara K, McCann RL, Hughes
GC. Utility of remote wireless pressure sensing for endovascular leak
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PART II: MEASURING INTRASAC PRESSURE
MEASUREMENTS IS OF NO BENEFIT TO THE
PATIENT
Paola De Rango, MD, Fabio Verzini, MD, and
Piergiorgio Cao, MD, Perugia and Rome, Italy
The goal of any treatment of aortic aneurysm is to
prevent rupture. From an endovascular standpoint, this
purpose is achieved by eliminating flow in the aneurysm sac.
Failure to completely exclude the aneurysm from the sys-
temic circulation (eg, endoleak, endotension) results in
continued pressurization and persisting risk of expansion/
rupture. Measurement of sac pressure provides a physiolog-
ical assessment of success. After the first experiences showing
feasibility and reliability of direct percutaneous translumbar
intrasac pressure measurement with catheters1,2 the develop-
ment of minimally invasive implantable telemetric pressure
sensors was increasingly advocated in the last decade as an easy
and convenient method for surveillance after endovascular
aneurysm repair. To date, three different types of pressure
sensors (all implantable at the time of the endovascular proce-
dure and not containing any internal energy source battery)
using different technologies of transmitting the pressure
from inside the body to an external antenna have been
investigated. The Impressure AAA Sac Pressure Sensor
(Remon Medical Technologies, Caesarea, Israel) is ultra-
sound-based (ultrasounds activate the sensor and commu-
nicate with the external device); the CardioMEMS
EndoSure Wireless AAA Pressure Sensor (CardioMems,
Atlanta, Ga), the only pressure sensor with Food & Drug
Administration approval, is radiofrequency-based and con-
sists in a resonant circuit; the TPS Telemetric Pressure
Sensor (Helmhotz Institute for Biomedical Engineering
and the Institute of Materials in Electrical Engineering,
RWTH, Aachen, Germany), tested only in in vitro models,
is based on a completely digital microchip which transfers
digital data to an external monitoring station. In addition,
a new, non-electronic technology, called “acoustic pressure
sensing”, is currently under development by the Common-
wealth Scientific and Industrial Research Organisation in
Australia.
Even though monitoring the pressure within the aneu-
rysm sac with a catheter or an implantable sensor could be
an appealing means to predict the risk of aneurysm rupture,
whether this physiological monitor may obviate to the
necessity of further surveillance investigations after endo-
vascular aortic repair is debatable. Today there are notable
limitations to both direct transcatheter and sensor pressure
device usage.
Clinical relevance. Pressure monitoring has been in-
vestigated in vitro, in animal models and in small clinical
trials. Nevertheless, since clinical trials have not yet evalu-
ated a sufficient number of patients over the long-term (ie, peveral years), it is not clear how current protocols of
urveillance after endovascular repair might be changed
ithout failing to detect relevant adverse events such graft
igration. Ellozy et al,3 from an IDE study with Impres-
ure AAA Sac Pressure Transducer reported that mean
ressure was significantly lower in patients with sac shrink-
ge at 6 months and at final follow-up. However, pressure
ould be obtained only in 15 of the 21 patients implanted.
n 2008, two case series, both using the EndoSure radio-
requency device, were published.4,5 The first4 reported
nly on intraoperative use in a series of 19 patients. Al-
hough statistically significant correlation coefficients were
ound in all the comparisons between pressure sensors and
atheter measurements, values largely ranged from 0.50 to
.96. The second case series reported on postoperative
onitoring for endoleaks using the CardioMEMS
ndoSure sensor in 12 patients with 30-day follow-up.5
elivery of the sensor was complicated in 7% with no
btainable pressure reading.5 In the APEX study (Acute
ressure measurement to confirm aneurysm sac Exclusion)
he initial sensor pressure measurements matched with the
ngiographic catheter pressure measurements of type I and
II endoleak. However, of 90 enrolled patients, results
ere not reported in 14 due to “protocol violations, typi-
ally a missed measurement.”6 Authors concluded for the
eed of a definite “learning curve” associated with refining
he technique for insertion of the implants, interrogation of
he sensor, and operation of the electronics. Although
ome of these problems have been resolved with training
nd improvements in the systems by manufacturers, today
he available data supporting the efficacy of these devices
re provided from very few populations.
Key Message: Despite the efforts in providing reliable
ata with intrasac pressure measurements techniques, only
imited numbers and sporadic information have been
chieved.
Long-term efficacy of pressure monitoring systems
n preventing aneurysm rupture. Although some long-
erm studies are in progress, follow-up data from clinical
rials analyzing implantable devices (Impressure and
ardioMEMS EndoSure) have just approached 2 years,
hile most safety, efficacy, and accuracy published data
efer to end-procedural time or 30-month assessment. The
PEX trial provided data at the end of the procedure and at
0 days.6 Hoppe et al showed 1-month follow-up data
follow-up ranging 19-44 days).5 Ellozy et al3 reported
esults using the Impressure Transducer with a mean of 11
onths. Only sporadic information is provided in the long
erm. Specifically, the APEX study reported on a single
atient who underwent successful endovascular aortic re-
air with low sac pressure (sac/systolic pressure ratio 
.31) and then experienced an increase in sac pressure ratio
o 0.57 during follow-up at 12-month.6,7 A subsequent CT
can showed sac enlargement and a type II endoleak that
as repaired successfully. In another study, two type II
ndoleaks were detected: sac pressure was unchanged in
ne and decreased in the other5; in addition, a single
atient with a type III endoleak on CT had increasing sac
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Volume 53, Number 2 Milner et al 537pressure.5 Although some authors suggested that implant-
able pressure devices may remain functional and safe,3 no
one has advocated follow-up limited to pressure informa-
tion.
Key message: Long-term information of intrasac pressure
measurements is based only on anecdotal cases from clinical
trials and cannot provide a definitive clinical direction.
Indication for treatment. In clinical trials, implanted
pressure sensors were able to detect type I, type III, as well
as type II endoleaks, but a definitive proof of efficacy is
lacking. Specifically, the clinical relevance in detecting type
II endoleak is not yet clarified since these endoleaks were
found to be associated with different sac pressure. Elevated
and diminished sac pressures in the presence of endoleak
strongly rely on specific configurations of inflow and out-
flow channels through aortic collateral branches and cannot
predict their clinical relevance.3,6,7 For instance, in the
small clinical trial of Ellozy et al,3 a lumbar endoleak
thrombosed at 6 months but left an elevated intrasac pres-
sure while in the APEX trial, 4 patients showed a 30%
reduction in sac pressure but without any evidence of
endoleak at angiography.6 Unfortunately, there were no
data on the aneurysm diameter in these cases to support the
hypothesis of endotension due to sealed endoleak transmit-
ting systemic pressure to the excluded aneurysm sac.
There is also little information on endotension and
intrasac pressure. Dias et al8 recently reported data on
invasive transcatheter pressure monitoring in patients with-
out endoleak andwith unchanged aneurysm diameter more
than 1 year after endovascular aortic repair (EVAR).8 Au-
thors suggested that the presence of intrasac fluid was
associated with lower intrasac pressurization and thus bet-
ter prognosis. Nevertheless, only five aneurysms with in-
trasac fluid were analyzed: after 36 months, one shrank,
three remained unchanged while one expanded. No strong
message on how to manage endotension according to
intrasac pressure measurement can be supported by this
sporadic information.
Key message: The clinical relevance of type II endoleak as
well as endotension need to be further evaluated in future
studies over a longer time period and correlated with aneu-
rysm sac growth, diameter, and other adverse events besides
intrasac pressure.
Safety. A major drawback of direct percutaneous in-
trasac pressure measurement approach is its invasive nature.
Translumbar puncture of the sac can be safely accomplished
only in patients without special anatomical configurations
(eg, obesity, sac large enough to be accessed) increasing the
risk of the procedure (viscera or stent integrity preserva-
tion).8 Although the introduction of implantable pressure
sensor has supplanted most of these risks, information on
long-term complications of wireless implanted devices (eg,
radio frequency exposure, foreign body reaction, displace-
ment, infection) is lacking.
Applicability. Morphologic (patient anatomy) and
operators’ constraints strongly affect the applicability of
pressure measurements. Direct intrasac pressure measure-
ments are invasive procedures that can be safely performed tnly in selected centers with appropriate experience on
uitable patients morphologies. Implantable intrasac pres-
ure sensors require appropriate trained operators and cen-
ers available to afford the training and the cost of such
evices.
Key message: There are reasons to believe that today, but
lso in the future, pressure measurement will never become a
tandard routine practice, because such approach is neither
or all comers nor for all practitioners.
Setting the standard threshold. In most series it has
een accepted a decrease of 30% or more as a critical value
o assess decrease in sac pressurization. Nevertheless, a
efinitive pressure threshold for subsequent intervention
eeds to be defined by further studies. Indeed, the 30%
eduction cut-off has been applied to different measure-
ents. For the wireless devices experiences, Ohki et al
APEX study)6 used a 30% or more reduction in “pulse
ressure from the initial pressure” to define a sealed sac and
30% reduction in pulse pressure to indicate a type I or
ype III endoleak. This allowed a sensitivity and specificity
f the sensor for detection of type I and III endoleaks of
.80 and of 0.93, respectively compared with completion
ngiography. However, data accuracy refers to results de-
ected at the time of the procedure and not longer in the
ime. Dias et al reported on 18 direct percutaneous intrasac
ressure readings after EVAR and calculated the “mean
ressure index (MPI)  the percentage of mean intra-
neurysm pressure relative to the simultaneous mean intra-
ortic pressure.”1,8 MedianMPI was 26% in 5 patients with
hrinking sacs, 28% in 10 patients with unchanged sac and
3% in 3 patients with expanding aneurysms.8 Authors also
uggested that pulse pressure had a greater influence than
PI on diameter change.8
Key message: The sensitivity/specificity of pressure mea-
urements, including appropriate threshold pressures, is still
nclear.
Accuracy in measurement/malfunctioning. Each
pecific model of pressure-sensor measurement presents
pecific drawbacks that hopefully might be resolved by new
odels in the future. There is no clear advantage of one vs
nother. Direct translumbar percutaneous approach is in-
asive, while all the investigated implantable pressure sen-
ors either have to be fixed to the outer surface of the
ndograft (specifically the ultrasound-based Impressure)3,9
eading to an upsizing of the introducer sheath or have to
e deployed through their own catheter system (eg, the
ndoSure).5,6 To prevent the upsizing, in vitro and animal
tudies have been carried out with flexible and foldable
ireless passive pressure sensors but the downside of this
pproach was a significant baseline drift of the pressure
easurements, which needs to be improved in the future.10
adiofrequency-based sensors (EndoSure) have the advan-
age to consist in simple resonant circuits and not to require
o be fixed on the graft. Nevertheless, although the rela-
ively simple structure is robust, this does not provide any
rror correction for interferences from other external radio
requency fields. This interference is more pronounced in
he thoracic aneurysm endovascular repair (TEVAR) pop-
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ageal echocardiography and neurological monitoring.11
Parsa et al in a series of 43 TEVAR showed that the
presence of multiple radio frequency energy emitting de-
vices in the operating room allowed proper measurement
obtainable in only 47% of patients.11
Malpositioning of the sensor may lead to incorrect
pressure measurements. The Impressure sensor should be
attached to themain body of the endograft in a way that the
sensor will measure the pressure inside the excluded aneu-
rysm sac without being pushed against either the aneurysm
wall or the iliac limbs. Positioning the sensor between the
two limbs of the graft has resulted in less reliable pressure
measurements (compression artifacts) and should be avoi-
ded.3 Parsa et al reported a significant rate of malpositioned
EndoSure sensors during TEVAR: 22% with first genera-
tion decreasing to a not negligible 10% with last generation
devices.11 Moreover, proper positioning of pressure sensor
to detect reliable measurements may be difficult in saccular
aneurysms. Finally, the orientation of the pressure sensor
and the distance of the sensor in relation to the source of
pressure can also influence measurements.
Key message: Malposition, orientation and external in-
terference can significantly alter the reliability of measure-
ments with current available pressure sensor devices.
“Compartmentalization” (thrombus effect) of the
aneurysm. Previous works have demonstrated that pres-
sure measurements in the setting of documented endoleaks
may exhibit a lack of uniformity throughout the aneurysm
sac with consistently higher pressures measured in the
endoleak channels if compared with the surrounding aneu-
rysm thrombus. Even though the effect of thrombus in
dampening pressure measurements is supposed to be small
(ranging 5% to 15%) and does not change the reliability of
the pressure systems, a lack of uniformity in thrombus
structure may influence the transmission of pressure.12
Within an aneurysm sac, pressure is transmitted through
the clot following both the hydrostatic fluid pressure and
the direct contact with the thrombus.7 When the sensor is
placed within a closed system, these two pressures are
almost equal (10%) because the thrombus has enough
porosity to allow fluid to move around, and fluid is an
excellent vehicle to transmit pressure. Therefore, the sensor
will detect the sac pressure accurately, provided that the sac
is filled with fluid or clot as when it is surrounded by acute
clot immediately after successful endovascular graft deploy-
ment. However, usually thrombus consistence significantly
changes over the time becoming mostly organized and
fibrous with increased hampering effect on pressure trans-
mission. Long-term data to disprove or corroborate such
“attenuation effect” of old thrombus on pressure sensor
measurements are lacking.
All the pressure-sensing technologies are currently lim-
ited to sampling a restricted surface area of the stent graft
and the clinical correspondence of the measured changes is
still uncertain. In the presence of extensive aneurysms that
may involve multiple segments of the aorta (eg, thoracic
aneurysms) or situations where clear compartmentalizationnd unequal pressure distribution exist, more than one
ensormay be needed to increase the sensitivity in detecting
ndoleaks. However, not every aneurysm sac provides
nough space to accommodate more than one pressure
ensor and the question will have to be addressed in future
tudies with improved technologies.
Key message: In evaluating reliability of the results from
ntra-sac pressure measurements especially in the long term,
he potential effects of compartmentalization and the inter-
erence of thrombus within the sac should be considered.
Costs. Yet, a final consideration is financial: although
he service is today provided at no charge, each implant
ensor costs approximately $3,500.00, which approaches
hat of some endovascular components. Longer operative
ime and additional training should be also considered
hen doing an economic evaluation.11
ONCLUSIONS
Lifelong surveillance is necessary after endovascular
ortic repair. The effectiveness of measuring intrasac pres-
ure in the management of patients after endovascular
neurysm repair is still challenged by a number of unan-
wered questions, regarding safety (invasive direct punc-
ure, long-term complications of wireless implanted de-
ices) efficacy, accuracy (“sac compartmentalization”), and
pplicability.
Several factors determine aneurysm sac pressure after
ndovascular repair, including “graft-related” factors such
s endoleak, graft porosity, and graft compliance, and “an-
tomical-related” factors such as patency of aneurysm col-
ateral branches, aneurysm morphology, and the character-
stic of aneurysm thrombus. It is still debatable whether the
ffect of all these factors can be summarized in a single point
ressure value and how reliable the clinical relevance of this
ingle measurement in common clinical practice might be,
lso because of the inconsistent clinical evidence to support
hese hypotheses.
Thus, at least in current practice, until these important
uestions are addressed, invasive intrasac pressure measure-
ents cannot supplant serial imaging for the above stated
easons and are to be considered investigational in the
anagement of patients having endovascular aneurysm
epair. However, physiological measurements may serve as
useful diagnostic adjunct that permits expectant manage-
ent when low sac pressure is found in addition to low flow
ype II endoleak after endovascular repair.
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Although the need for long-term postoperative surveillance
after endovascular abdominal aortic aneurysm repair is universally
agreed upon, the specific surveillance regimen remains controver-
sial. Over the last number of years, we have seen the progression of
this surveillance from regular computerized tomography (CT)
scans to ultrasounds and plain films. Physiological or hemody-
namic surveillance has been explored via direct intrasac pressure
measurements or noninvasive sac pressure monitoring which is the
subject of the current debate between Dr Milner and Professor
Cao.
Before the development of this technology, aneurysm sac
behavior, as determined by CT scans or ultrasound scans, was used
as a surrogate marker for sac pressurization. It is assumed that a
shrinking aneurysm is a sign of a successfully excluded aneurysm,hD, London, Ontario, Canada; and Poitiers, France
ents of intrasac pressure monitoring envisioned a role for this
echnology in determining which type II endoleaks in stable aneu-
ysm sacs required further intervention. As type II endoleak devel-
pment and behavior is unpredictable, sensors would have to be
mplanted in all patients if they are to benefit this group. Therefore,
he question remains whether the additional cost of such implants
s warranted given the current information available.
DrMilner and Professor Cao outline the information obtained
o date, and seem to arrive at similar conclusions. Although there is
vidence to support the usefulness of implantable sensors in se-
ected individual patients, this is often after the fact and there is
nsufficient evidence to support their implantation in all patients
ndergoing endovascular aneurysm repair. However, they have
llowed us to learn more about sac pressure patterns and behavior
ost repair, and have moved us closer to a truly noninvasive,
hysiological based surveillance tool.
